Published in Medical Letter on the CDC and FDA, September 3rd, 2006
Sales for the first quarter ended July 28, 2006 are expected to be approximately $33.5 million, compared to fiscal year 2006 first quarter sales of $27.0 million, reflecting annual growth of 24% from the same period last year. U.S. sales for the first quarter ended July 28, 2006 are expected to be approximately $29.4 million, and international sales for the first quarter ended July 28, 2006 are expected to be approximately $4.1 million.
Cash and marketable securities are expected to increase from $92.3 million at April 28, 2006 to approximately $94.0 million at July 28, 2006 and borrowings...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.